Publication | Closed Access

Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

UrologyPancreatic CancerGastrointestinal OncologyMedicinePharmacotherapyMolecular OncologyMetastatic Pancreatic CancerFrontline TreatmentCancer TreatmentOncologyRadiation OncologyCancer Research